{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"contributor": "Liz Moyer contributed reporting.", "original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "Pfizer is near agreement to buy rival drug maker Allergan for up to $150 billion.", "type_of_material": "News", "word_count": "580", "lead_paragraph": "A merger would create a drug giant with nearly $53 billion in annual sales and give Pfizer a long-sought foreign headquarters for tax purposes.", "pub_date": "2015-11-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Pfizer and Allergan Said to Be Near Merger for Up to $150 Billion", "print_headline": "Pfizer and Allergan Said to Be Close to $150 Billion Merger"}, "snippet": "A merger would create a drug giant with nearly $53 billion in annual sales and give Pfizer a long-sought foreign headquarters for tax purposes.", "multimedia": [{"height": 126, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/20/business/db-drug-web1/db-drug-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/20/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/19/business/dealbook/pfizer-allergan-deal-for-up-to-150-billion-is-said-to-be-close-to-complete.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Tax Shelters", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Corporate Taxes", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "564d2aff38f0d81eb3ced09c", "source": "The New York Times"}